Legend’s $424M NASDAQ offering pads 2020’s lead over prior years

This year’s IPO tally stands at $6.2B, ahead of the past two years thanks to larger deals

Closely-watched CAR T company Legend raised more than $400 million Friday in the year's largest biotech IPO thus far. The deal helped push the total raised via life sciences IPOs to $6.2 billion, outpacing the past two years thanks to larger deals, even as the pandemic has roiled markets around the globe.

Life sciences IPOs raised $3.6

Read the full 565 word article

How to gain access

Continue reading with a
two-week free trial.